Clinical Trials Directory

Trials / Completed

CompletedNCT04707144

Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T

Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
106 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Inclusion visit (D0): * verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), o 3D STIR sequence. * 3D PSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 45 minutes (instead of 35 minutes).

Conditions

Interventions

TypeNameDescription
DEVICEMRI 1.5 tesla* standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), o 3D STIR sequence. * 3D PSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 45 minutes (instead of 35 minutes)

Timeline

Start date
2021-05-06
Primary completion
2023-06-06
Completion
2023-06-28
First posted
2021-01-13
Last updated
2023-12-13

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04707144. Inclusion in this directory is not an endorsement.